These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17462080)

  • 1. Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study.
    Hanefeld M; Koehler C; Gallo S; Benke I; Ott P
    Cardiovasc Diabetol; 2007 Apr; 6():13. PubMed ID: 17462080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study.
    Najarian RM; Sullivan LM; Kannel WB; Wilson PW; D'Agostino RB; Wolf PA
    Arch Intern Med; 2006 Jan; 166(1):106-11. PubMed ID: 16401818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the prevalence of the metabolic syndrome by WHO, AHA/NHLBI, and IDF definitions in a German population with type 2 diabetes: the Diabetes in Germany (DIG) Study.
    Koehler C; Ott P; Benke I; Hanefeld M;
    Horm Metab Res; 2007 Sep; 39(9):632-5. PubMed ID: 17846969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts?
    Iribarren C; Go AS; Husson G; Sidney S; Fair JM; Quertermous T; Hlatky MA; Fortmann SP
    J Am Coll Cardiol; 2006 Nov; 48(9):1800-7. PubMed ID: 17084253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic syndrome in type 2 diabetes: When does it matter?
    Wong J; Molyneaux L; Constantino MI; Twigg SM; Yue DK
    Diabetes Obes Metab; 2006 Nov; 8(6):690-7. PubMed ID: 17026494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic syndrome, incidence of diabetes and mortality among the elderly: the Italian Longitudinal Study of Ageing.
    Noale M; Maggi S; Zanoni S; Limongi F; Zambon S; Crepaldi G;
    Diabetes Metab; 2012 Apr; 38(2):135-41. PubMed ID: 22071281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction model with metabolic syndrome to predict recurrent vascular events in patients with clinically manifest vascular diseases.
    Wassink AM; van der Graaf Y; Janssen KJ; Cook NR; Visseren FL;
    Eur J Prev Cardiol; 2012 Dec; 19(6):1486-95. PubMed ID: 22008749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent predictors of metabolic syndrome in HIV-infected patients.
    Alencastro PR; Fuchs SC; Wolff FH; Ikeda ML; Brandão AB; Barcellos NT
    AIDS Patient Care STDS; 2011 Nov; 25(11):627-34. PubMed ID: 21936688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study.
    Athyros VG; Bouloukos VI; Pehlivanidis AN; Papageorgiou AA; Dionysopoulou SG; Symeonidis AN; Petridis DI; Kapousouzi MI; Satsoglou EA; Mikhailidis DP;
    Diabetes Obes Metab; 2005 Jul; 7(4):397-405. PubMed ID: 15955126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using structural equation model to illustrate the relationship between metabolic risk factors and cardiovascular complications in Taiwan.
    Lin JW; Hwang JJ; Dai DF; Tseng YZ
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):633-9. PubMed ID: 16874156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of metabolic syndrome and Framingham cardiovascular risk scores in adult inpatients taking antipsychotics - a retrospective medical records review.
    Wysokiński A; Kowman M; Kłoszewska I
    Psychiatr Danub; 2012 Sep; 24(3):314-22. PubMed ID: 23013638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum uric acid level is associated with metabolic syndrome and microalbuminuria in Korean patients with type 2 diabetes mellitus.
    Kim ES; Kwon HS; Ahn CW; Lim DJ; Shin JA; Lee SH; Cho JH; Yoon KH; Kang MI; Cha BY; Son HY
    J Diabetes Complications; 2011; 25(5):309-13. PubMed ID: 21130003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization.
    Protack CD; Bakken AM; Xu J; Saad WA; Lumsden AB; Davies MG
    J Vasc Surg; 2009 May; 49(5):1172-80.e1; discussion 1180. PubMed ID: 19394545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and the development of type 2 diabetes among professionals living in Beijing, China.
    Zeng P; Zhu X; Zhang Y; Wang S; Zhang T
    Diabetes Res Clin Pract; 2011 Nov; 94(2):299-304. PubMed ID: 21920619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort.
    Athyros VG; Liberopoulos EN; Mikhailidis DP; Papageorgiou AA; Ganotakis ES; Tziomalos K; Kakafika AI; Karagiannis A; Lambropoulos S; Elisaf M
    Angiology; 2007 Dec-2008 Jan; 58(6):689-97. PubMed ID: 18216378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
    Onat A; Hergenç G; Can G; Küçükdurmaz Z
    Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of metabolic syndrome in Japanese type 2 diabetic patients and its significance for chronic vascular complications.
    Shimajiri Y; Tsunoda K; Furuta M; Kadoya Y; Yamada S; Nanjo K; Sanke T
    Diabetes Res Clin Pract; 2008 Feb; 79(2):310-7. PubMed ID: 17933413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
    Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
    J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
    Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
    Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
    Lim HS; Lip GY; Beevers DG; Blann AD
    Eur J Clin Invest; 2005 May; 35(5):324-9. PubMed ID: 15860044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.